NMTC Stock Overview
NeuroOne Medical Technologies Corporation operates as a medical technology company.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
NeuroOne Medical Technologies Corporation Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$1.12 |
| 52 Week High | US$2.00 |
| 52 Week Low | US$0.85 |
| Beta | 1.06 |
| 1 Month Change | -5.08% |
| 3 Month Change | -15.79% |
| 1 Year Change | -28.66% |
| 3 Year Change | -82.66% |
| 5 Year Change | -90.55% |
| Change since IPO | -90.67% |
Recent News & Updates
Recent updates
Is NeuroOne Medical Technologies (NASDAQ:NMTC) In A Good Position To Deliver On Growth Plans?
Dec 16
Can NeuroOne Medical Technologies (NASDAQ:NMTC) Afford To Invest In Growth?
Jul 25Here's Why We're Watching NeuroOne Medical Technologies' (NASDAQ:NMTC) Cash Burn Situation
Apr 11We Think NeuroOne Medical Technologies (NASDAQ:NMTC) Needs To Drive Business Growth Carefully
Sep 15NeuroOne rallies on receiving $3.5M in accelerated milestone payment from Zimmer Biomet
Aug 03Is NeuroOne Medical Technologies (NASDAQ:NMTC) In A Good Position To Deliver On Growth Plans?
Jun 02Companies Like NeuroOne Medical Technologies (NASDAQ:NMTC) Could Be Quite Risky
Dec 18NeuroOne: Thin Film Electrodes For Diagnosis And Treatment Of Neurological Conditions
Nov 19Will NeuroOne Medical Technologies (NASDAQ:NMTC) Spend Its Cash Wisely?
Sep 04We're Not Very Worried About NeuroOne Medical Technologies' (NASDAQ:NMTC) Cash Burn Rate
May 27Shareholder Returns
| NMTC | US Medical Equipment | US Market | |
|---|---|---|---|
| 7D | -2.6% | -2.9% | -3.2% |
| 1Y | -28.7% | -3.7% | 19.3% |
Return vs Industry: NMTC underperformed the US Medical Equipment industry which returned -3.7% over the past year.
Return vs Market: NMTC underperformed the US Market which returned 19.3% over the past year.
Price Volatility
| NMTC volatility | |
|---|---|
| NMTC Average Weekly Movement | 13.1% |
| Medical Equipment Industry Average Movement | 7.4% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 16.5% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: NMTC's share price has been volatile over the past 3 months.
Volatility Over Time: NMTC's weekly volatility (13%) has been stable over the past year, but is still higher than 75% of US stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2009 | 16 | Dave Rosa | www.n1mtc.com |
NeuroOne Medical Technologies Corporation operates as a medical technology company. The company focuses on the development and commercialization of thin film electrode technology for continuous electroencephalogram (cEEG) and stereoelectroencephalography (sEEG) recording, spinal cord stimulation, brain stimulation, and ablation solutions for patients suffering from epilepsy, Parkinson’s disease, dystonia, essential tremors, chronic pain due to failed back surgeries, and other related neurological disorders. It has a strategic partnership with RBC Medical Innovations to develop a radio frequency ablation generator.
NeuroOne Medical Technologies Corporation Fundamentals Summary
| NMTC fundamental statistics | |
|---|---|
| Market cap | US$29.56m |
| Earnings (TTM) | -US$13.47m |
| Revenue (TTM) | US$2.82m |
10.3x
P/S Ratio-2.2x
P/E RatioIs NMTC overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| NMTC income statement (TTM) | |
|---|---|
| Revenue | US$2.82m |
| Cost of Revenue | US$8.94m |
| Gross Profit | -US$6.13m |
| Other Expenses | US$7.35m |
| Earnings | -US$13.47m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.52 |
| Gross Margin | -217.56% |
| Net Profit Margin | -478.48% |
| Debt/Equity Ratio | 0% |
How did NMTC perform over the long term?
See historical performance and comparison